Immunotherapy Research in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Immunotherapy Research in Argentina

Immunotherapy Research in Argentina – CRO South America

Immunotherapy, a groundbreaking field in medical science, has revolutionized cancer treatment worldwide. By harnessing the power of the immune system, immunotherapy offers a promising avenue for more effective and targeted cancer therapies.

In recent years, Argentina has emerged as a leading contributor to innovative immunotherapy research, making significant strides in this field. This blog will explore the remarkable progress made in immunotherapy research in Argentina and highlight key initiatives and breakthroughs that have the potential to transform cancer treatment globally.

The Growth of Immunotherapy Research in Argentina:

Argentina has experienced significant growth in immunotherapy research, with renowned academic institutions, research centers, and hospitals at the forefront. These institutions have invested substantial resources and efforts in understanding the mechanisms underlying immunotherapy and developing novel treatment approaches.

This surge in research activity has attracted top-tier scientists, medical professionals, and industry experts, fostering a vibrant ecosystem for collaboration and innovation.

Collaboration and Partnerships:

A key factor contributing to the success of immunotherapy research in Argentina is the emphasis on collaboration and partnerships. Academic institutions such as the National University of La Plata, the National Cancer Institute (INC), and the Argentine Society of Cancer Research (SAIC) actively collaborate with international research centers and pharmaceutical companies.

These partnerships facilitate knowledge exchange, access to cutting-edge technologies, and the development of clinical trials, accelerating progress in immunotherapy research.

Development of Innovative Immunotherapies:

Argentinian researchers have made significant strides in the development of innovative immunotherapies for various types of cancer. They are focusing on developing cancer vaccines, immune checkpoint inhibitors, adoptive cell therapies, and other groundbreaking treatments.

For instance, scientists at the National University of Rosario have conducted extensive research on cancer vaccines that stimulate the immune system to target and eliminate cancer cells. These efforts have shown promising results in clinical trials, offering hope to patients in Argentina and beyond.

Immunotherapy Research in Argentina

Immunotherapy Research in Argentina

Immunotherapy Research in Argentina

Personalized Medicine and Genetic Research:

Immunotherapy research in Argentina is characterized by a focus on personalized medicine and genetic research. Researchers are exploring the genetic and environmental factors that influence cancer development in the Argentine population.

By tailoring immunotherapeutic approaches to the specific needs and characteristics of Argentine patients, researchers aim to optimize treatment outcomes and address healthcare disparities. This personalized approach ensures that immunotherapy is accessible and effective for a broader patient population.

Clinical Trials and Patient Access:

Argentina has become an important destination for conducting clinical trials in immunotherapy. The country’s well-established regulatory framework, diverse patient population, and robust healthcare infrastructure make it an ideal location for testing and validating novel immunotherapeutic interventions.

Clinical trials not only provide Argentine patients with access to cutting-edge treatments but also contribute valuable data to global research efforts.

Challenges and Future Directions:

While immunotherapy research in Argentina has made significant progress, several challenges remain. These include the need for increased funding, further strengthening of research infrastructure, and enhancing collaboration between academia, industry, and government agencies.

Addressing these challenges will require sustained efforts and continued investment in scientific research and innovation.

Looking ahead, the future of immunotherapy research in Argentina is highly promising. The country’s commitment to scientific advancement, the presence of esteemed research institutions, and the dedication of researchers and healthcare professionals bode well for further breakthroughs in cancer treatment.

By expanding clinical trials, fostering international collaborations, and prioritizing patient-centric approaches, Argentina has the potential to become a leading force in immunotherapy research and significantly contribute to the fight against cancer.


Immunotherapy research in Argentina has witnessed significant growth, positioning the country as a major contributor to the development of innovative cancer treatments.

Through collaboration, scientific excellence, and personalized medicine, Argentina is driving advancements in immunotherapy that have the potential to transform cancer treatment not only within its borders but also on a global scale.

With a strong emphasis on collaboration, partnerships, and personalized medicine, researchers in Argentina are paving the way for improved patient outcomes and a more targeted approach to cancer therapy.

Immunotherapy Research in Argentina

Source: World Courier

Immunotherapy Research in Argentina
Cohortias the CRO of LATAM

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Immunotherapy Research in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Immunotherapy Research in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Immunotherapy Research in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Immunotherapy Research in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Immunotherapy Research in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Immunotherapy Research in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Immunotherapy Research in Argentina

The Cohortias Team

Immunotherapy Research in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Immunotherapy Research in Argentina

Network & Partnerships